ADWYA has published its financial statements for the year ended December 31, 2019.
Its statements show a net profit of 1.5 million dinars, against 3.1 million a year earlier, a decrease of 50%.
Last year, the company achieved revenues of 105.6 million dinars, compared to 108.2 million in 2018, thus posting a slight decline of 2%.
These revenues are mainly composed of sales of finished pharmacy products under license (60.6 million dinars) and sales of finished pharmacy products ADWYA (39.6 million).
As for operating expenses, they grew from 104.6 million dinars in 2018 to 103.3 million dinars at the end of December 2019, including 67.2 million dinars for the purchase of raw materials and 15.5 million dinars for personnel costs.
The operating result therefore shows a sharp fall of 49.3% to 5.6 million dinars, compared to 11 million dinars a year earlier.
